Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy

References

• United Nations. World social report 2023: leaving no one behind in an ageing world | UN DESA Publications [Internet]. 2023. Available from: https://desapublications.un.org/publications/world-social-report-2023-leaving-no-one-behind-ageing-world.
   Google Scholar
• Chowdhury SR, Chandra Das D, Sunna TC, et al. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. eClinicalMedicine. 2023;57:101860–101860. doi:10.1016/j.eclinm.2023.101860
   PubMedGoogle Scholar
• Makovski TT, Schmitz S, Zeegers MP, et al. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019;53:100903–100903. doi:10.1016/j.arr.2019.04.005
   PubMed Web of Science ®Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. The hallmarks of aging. Cell. 2013;153:1194–1217. doi:10.1016/j.cell.2013.05.039
   PubMed Web of Science ®Google Scholar
• Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22:601. doi:10.1186/s12877-022-03279-x
   PubMed Web of Science ®Google Scholar
• Midão L, Brochado P, Almada M, et al. Frailty status and polypharmacy predict all-cause mortality in community dwelling older adults in Europe. Int J Environ Res Public Health. 2021;18:3580. doi:10.3390/ijerph18073580
   PubMedGoogle Scholar
• Doumat G, Daher D, Itani M, et al. The effect of polypharmacy on healthcare services utilization in older adults with comorbidities: a retrospective cohort study. BMC Prim Care. 2023;24:120. doi:10.1186/s12875-023-02070-0
   PubMedGoogle Scholar
• Sinnott C, Mc Hugh S, Browne J, et al. GPs’ perspectives on the management of patients with multimorbidity: systematic review and synthesis of qualitative research. BMJ Open. 2013;3:e003610. doi:10.1136/bmjopen-2013-003610
   PubMed Web of Science ®Google Scholar
• O’Mahony D, Rochon PA. Prescribing cascades: we see only what we look for: we look for only what we know. Age Ageing. 2022;51:afac138. doi:10.1093/ageing/afac138
   PubMed Web of Science ®Google Scholar
• Kennedy BK, Berger SL, Brunet A, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159:709–713. doi:10.1016/j.cell.2014.10.039
   PubMed Web of Science ®Google Scholar
• Van Der Graaf PH, Gabrielsson J. Pharmacokinetic–pharmacodynamic reasoning in drug discovery and early development. Future Med Chem. 2009;1:1371–1374. doi:10.4155/fmc.09.124
   PubMed Web of Science ®Google Scholar
• O’Connor A, O’Moráin C. Digestive function of the stomach. Dig Dis Basel Switz. 2014;32:186–191. doi:10.1159/000357848
   PubMed Web of Science ®Google Scholar
• Nandagopalan PA, Magdalene KF, Binu A. Effect of aging on the quantitative number of Brunner’s glands. J Clin Diagn Res JCDR. 2014;8:4–4.
   PubMedGoogle Scholar
• Zhou R, Moench P, Heran C, et al. pH-Dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model. Pharm Res. 2005;22:188–192. doi:10.1007/s11095-004-1185-3
   PubMed Web of Science ®Google Scholar
• Pang J, Dalziel G, Dean B, et al. Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs - reversing the effect of elevated gastric pH with betaine HCl. Mol Pharm. 2013;10:4024–4031. doi:10.1021/mp400356m
   PubMedGoogle Scholar
• Phillips RJ, Kieffer EJ, Powley TL. Aging of the myenteric plexus: neuronal loss is specific to cholinergic neurons. Auton Neurosci Basic Clin. 2003;106:69–83. doi:10.1016/S1566-0702(03)00072-9
   PubMed Web of Science ®Google Scholar
• Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, et al. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc. 2009;21:746-e46. https://pubmed-ncbi-nlm-nih-gov.uchile.idm.oclc.org/19220755/
   Google Scholar
• Wiskur B, Greenwood-Van Meerveld B. The aging colon: the role of enteric neurodegeneration in constipation. Curr Gastroenterol Rep. 2010;12:507–512. doi:10.1007/s11894-010-0139-7
   PubMedGoogle Scholar
• McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. 2011;71:351–364. doi:10.1111/j.1365-2125.2010.03847.x
   PubMed Web of Science ®Google Scholar
• Farage MA, Miller KW, Elsner P, et al. Characteristics of the aging skin. Adv Wound Care. 2013;2:5–10. doi:10.1089/wound.2011.0356
   PubMedGoogle Scholar
• Miller MR. Structural and physiological age-associated changes in aging lungs. Semin Respir Crit Care Med. 2010;31:521–527. doi:10.1055/s-0030-1265893
   PubMed Web of Science ®Google Scholar
• Hochhegger B, de Meireles GP, Irion K, et al. O tórax e o envelhecimento: manifestações radiológicas. J Bras Pneumol. 2012;38:656–665. doi:10.1590/S1806-37132012000500016
   PubMedGoogle Scholar
• Sprung J, Gajic O, Warner DO. Review article: age related alterations in respiratory function - anesthetic considerations. Can J Anesth. 2006;53:1244–1257. doi:10.1007/BF03021586
   PubMed Web of Science ®Google Scholar
• Ishaq A, Schröder J, Edwards N, et al. Dietary restriction ameliorates age-related increase in DNA damage,: senescence and inflammation in mouse adipose tissuey. J Nutr Health Aging. 2018;22:555–561. doi:10.1007/s12603-017-0968-2
   PubMed Web of Science ®Google Scholar
• Hughes VA, Roubenoff R, Wood M, et al. Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr. 2004;80:475–482. doi:10.1093/ajcn/80.2.475
   PubMed Web of Science ®Google Scholar
• Lei SF, Liu MY, Chen XD, et al. Relationship of total body fatness and five anthropometric indices in Chinese aged 20–40 years: different effects of age and gender. Eur J Clin Nutr. 2006;60:511–518. doi:10.1038/sj.ejcn.1602345
   PubMed Web of Science ®Google Scholar
• Raguso CA, Kyle U, Kossovsky MP, et al. A 3-year longitudinal study on body composition changes in the elderly: role of physical exercise. Clin Nutr. 2006;25:573–580. doi:10.1016/j.clnu.2005.10.013
   PubMed Web of Science ®Google Scholar
• Mitchell WK, Williams J, Atherton P, et al. Sarcopenia: dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol. 2012;3:260–260. doi:10.3389/fphys.2012.00260
   PubMed Web of Science ®Google Scholar
• Rodríguez-Julbe MC, Ramírez-Ronda CH, Arroyo E, et al. Antibiotics in older adults. P R Health Sci J. 2004;23:25–33.
   PubMedGoogle Scholar
• Hanratty CG, McGlinchey P, Johnston GD, et al. Differential pharmacokinetics of digoxin in elderly patients. Drugs Aging. 2000;17:353–362. doi:10.2165/00002512-200017050-00003
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Harmatz JS, Zhang Q, et al. Slow accumulation and elimination of diazepam and its active metabolite with extended treatment in the elderly. J Clin Pharmacol. 2021;61:193–203. doi:10.1002/jcph.1726
   PubMed Web of Science ®Google Scholar
• Cabrerizo S, Cuadras D, Gomez-Busto F, et al. Serum albumin and health in older people: review and meta analysis. Maturitas. 2015;81:17–27. doi:10.1016/j.maturitas.2015.02.009
   PubMed Web of Science ®Google Scholar
• Chudzik M, Maciązek-Jurczyk M, Pawełczak B, et al. Spectroscopic studies on the molecular ageing of serum albumin. Mol Basel Switz. 2016;22:E34–E34.
   Google Scholar
• Silva-Fhon JR, Rojas-Huayta VM, Aparco-Balboa JP, et al. Sarcopenia and blood albumin: a systematic review with meta-analysis. Biomed Rev Inst Nac Salud. 2021;41:590–603.
   Google Scholar
• Park HN, Song MJ, Choi YE, et al. LRG1 promotes ECM integrity by activating the TGF-β signaling pathway in fibroblasts. Int J Mol Sci. 2023;24:12445. doi:10.3390/ijms241512445
   PubMed Web of Science ®Google Scholar
• Grandison MK, Boudinot FD. Age-related changes in protein binding of drugs. Clin Pharmacokinet 2000. 2012;383:271–290.
   Google Scholar
• Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71:115–121. doi:10.1067/mcp.2002.121829
   PubMed Web of Science ®Google Scholar
• Warren A, Chaberek S, Ostrowski K, et al. Effects of old age on vascular complexity and dispersion of the hepatic sinusoidal network. Microcirculation. 2008;15:191–191. doi:10.1080/10739680701600856
   PubMed Web of Science ®Google Scholar
• Tajiri K, Shimizu Y. Liver physiology and liver diseases in the elderly. World J Gastroenterol. 2013;19:8459–8467. doi:10.3748/wjg.v19.i46.8459
   PubMed Web of Science ®Google Scholar
• Rattanacheeworn P, Kerr SJ, Kittanamongkolchai W, et al. Quantification of CYP3A and drug transporters activity in healthy young, healthy elderly and chronic kidney disease elderly patients by a microdose cocktail approach. Front Pharmacol. 2021;12:726669. doi:10.3389/fphar.2021.726669
   PubMed Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41:67–76. doi:10.1080/03602530902722679
   PubMed Web of Science ®Google Scholar
• Long DA, Mu W, Price KL, et al. Blood vessels and the aging kidney. Nephron Exp Nephrol. 2005;101:e95–e99. doi:10.1159/000087146
   PubMed Web of Science ®Google Scholar
• Emamian SA, Nielsen MB, Pedersen JF, et al. Kidney dimensions at sonography: correlation with age,: sex, and habitus in 665 adult volunteers. AJR. Am J Roentgenol. 2013;160:83–86. doi:10.2214/ajr.160.1.8416654
   Google Scholar
• Gourtsoyiannis N, Prassopoulos P, Cavouras D, et al. The thickness of the renal parenchyma decreases with age: a CT study of 360 patients. AJR. Am J Roentgenol. 2013;155:541–544. doi:10.2214/ajr.155.3.2117353
   Google Scholar
• Roseman DA, Hwang SJ, Oyama-Manabe N, et al. Clinical associations of total kidney volume: the Framingham heart study. Nephrol Dial Transplant. 2017;32:1344–1350.
   PubMed Web of Science ®Google Scholar
• Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int. 2008;74:710–720. doi:10.1038/ki.2008.319
   PubMed Web of Science ®Google Scholar
• Denic A, Lieske JC, Chakkera HA, et al. The substantial loss of nephrons in healthy human kidneys with aging. J Am Soc Nephrol. 2017;28:313–320. doi:10.1681/ASN.2016020154
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 2012;82:270–277. doi:10.1038/ki.2012.65
   PubMed Web of Science ®Google Scholar
• Bolignano D, Mattace-Raso F, Sijbrands EJG, et al. The aging kidney revisited: a systematic review. Ageing Res Rev. 2014;14:65–80. doi:10.1016/j.arr.2014.02.003
   PubMed Web of Science ®Google Scholar
• Glassock RJ, Rule AD. Aging and the kidneys: anatomy, physiology and consequences for defining chronic kidney disease. Nephron. 2016;134:25–29. doi:10.1159/000445450
   PubMed Web of Science ®Google Scholar
• O’Sullivan ED, Hughes J, Ferenbach DA. Renal aging: causes and consequences. J Am Soc Nephrol JASN. 2017;28:407–420. doi:10.1681/ASN.2015121308
   PubMed Web of Science ®Google Scholar
• James MT, Hemmelgarn BR, Wiebe N, et al. Glomerular filtration rate, proteinuria, and the incidence and consequences of acute kidney injury: a cohort study. Lancet. 2010;376:2096–2103. doi:10.1016/S0140-6736(10)61271-8
   PubMed Web of Science ®Google Scholar
• López-Otín C, Blasco MA, Partridge L, et al. Hallmarks of aging: an expanding universe. Cell. 2023;186:243–278. doi:10.1016/j.cell.2022.11.001
   PubMed Web of Science ®Google Scholar
• Martínez de Toda I, Ceprián N, Díaz-Del Cerro E, et al. The role of immune cells in oxi-inflamm-aging. Cells. 2021;10:2974. doi:10.3390/cells10112974
   PubMed Web of Science ®Google Scholar
• Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem. 2017;86:715–748. doi:10.1146/annurev-biochem-061516-045037
   PubMed Web of Science ®Google Scholar
• Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. 2008;295:C849–C868. doi:10.1152/ajpcell.00283.2008
   PubMed Web of Science ®Google Scholar
• Liu X, Hussain R, Mehmood K, et al. Mitochondrial-endoplasmic reticulum communication-mediated oxidative stress and autophagy. BioMed Res Int. 2022;2022.6459585. doi:10.1155/2022/6459585. PMID: 36164446.
   Web of Science ®Google Scholar
• Sies H. Chapter 13 - Oxidative stress: eustress and distress in redox homeostasis. In: Fink G, editor. Stress physiol biochem pathol. Düsseldorf, Germany: Academic Press; 2019. p. 153–163. [cited 2023 Nov 11]. Available from: https://www.sciencedirect.com/science/article/pii/B9780128131466000138.
   Google Scholar
• Janaszak-Jasiecka A, Płoska A, Wierońska JM, et al. Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets. Cell Mol Biol Lett. 2023;28:21. doi:10.1186/s11658-023-00423-2
   PubMed Web of Science ®Google Scholar
• Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289:7038–7050. doi:10.1111/febs.16059
   PubMed Web of Science ®Google Scholar
• Sies H. Total antioxidant capacity: Appraisal of a Concept12. J Nutr. 2007;137:1493–1495. doi:10.1093/jn/137.6.1493
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yamamoto M. Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress. J Biol Chem. 2017;292:16817–16824. doi:10.1074/jbc.R117.800169
   PubMed Web of Science ®Google Scholar
• Kurutas EB. The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J. 2016;151:1–22.
   Google Scholar
• Lesnefsky EJ, Gudz TI, Moghaddas S, et al. Aging decreases electron transport complex III activity in heart interfibrillar mitochondria by alteration of the cytochrome c binding site. J Mol Cell Cardiol. 2001;33:37–47. doi:10.1006/jmcc.2000.1273
   PubMed Web of Science ®Google Scholar
• Miwa S, Kashyap S, Chini E, et al. Mitochondrial dysfunction in cell senescence and aging. J Clin Invest. 2022;132:e158447. doi:10.1172/JCI158447
   PubMed Web of Science ®Google Scholar
• Boengler K, Kosiol M, Mayr M, et al. Mitochondria and ageing: role in heart,: skeletal muscle and adipose tissue. J Cachexia Sarcopenia Muscle. 2017;8:349–369. doi:10.1002/jcsm.12178
   PubMed Web of Science ®Google Scholar
• Miwa S, Jow H, Baty K, et al. Low abundance of the matrix arm of complex I in mitochondria predicts longevity in mice. Nat Commun. 2014;5:3837–3837. doi:10.1038/ncomms4837
   PubMed Web of Science ®Google Scholar
• Espinoza SE, Guo H, Fedarko N, et al. Glutathione peroxidase enzyme activity in aging. J Gerontol A Biol Sci Med Sci. 2008;63:505–509. doi:10.1093/gerona/63.5.505
   PubMed Web of Science ®Google Scholar
• Aigner T, Fundel K, Saas J, et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum. 2006;54:3533–3544. doi:10.1002/art.22174
   PubMed Web of Science ®Google Scholar
• Ruiz-Romero C, Calamia V, Mateos J, et al. Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics: a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol Cell Proteomics MCP. 2008;8:172–189. doi:10.1074/mcp.M800292-MCP200
   PubMed Web of Science ®Google Scholar
• Scott JL, Gabrielides C, Davidson RK, et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis. 2010;69:1502–1510. doi:10.1136/ard.2009.119966
   PubMed Web of Science ®Google Scholar
• Nissanka N, Moraes CT. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. FEBS Lett. 2018;592:728–742. doi:10.1002/1873-3468.12956
   PubMed Web of Science ®Google Scholar
• Bota DA, Davies KJA. Mitochondrial Lon protease in human disease and aging: including an etiologic classification of Lon-related diseases and disorders. Free Radic Biol Med. 2016;100:188–198. doi:10.1016/j.freeradbiomed.2016.06.031
   PubMed Web of Science ®Google Scholar
• Ahola S, Langer T, Macvicar T, et al. Mitochondrial proteolysis and metabolic control. Cold Spring Harb Perspect Biol. 2019;11:a033936–a033936. doi:10.1101/cshperspect.a033936
   PubMed Web of Science ®Google Scholar
• Sebastián D, Sorianello E, Segalés J, et al. Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J. 2016;35:1677–1693. doi:10.15252/embj.201593084
   PubMed Web of Science ®Google Scholar
• Chun SK, Lee S, Flores-Toro J, et al. Loss of sirtuin 1 and mitofusin 2 contributes to enhanced ischemia/reperfusion injury in aged livers. Aging Cell. 2018;17:e12761–e12761. doi:10.1111/acel.12761
   PubMed Web of Science ®Google Scholar
• Medala VK, Gollapelli B, Dewanjee S, et al. Mitochondrial dysfunction,: mitophagy, and role of dynamin-related protein 1 in Alzheimer’s disease. J Neurosci Res. 2021;99:1120–1135. doi:10.1002/jnr.24781
   PubMed Web of Science ®Google Scholar
• Alexeyev MF. Is there more to aging than mitochondrial DNA and reactive oxygen species? FEBS J. 2009;276:5768–5787. doi:10.1111/j.1742-4658.2009.07269.x
   PubMed Web of Science ®Google Scholar
• Wolf AM. MtDNA mutations and aging—not a closed case after all? Signal Transduct Target Ther. 2021;6.56.
   PubMed Web of Science ®Google Scholar
• Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell. 2006;127:1109–1122. doi:10.1016/j.cell.2006.11.013
   PubMed Web of Science ®Google Scholar
• Lira VA, Benton CR, Yan Z, et al. PGC-1α regulation by exercise training and its influences on muscle function and insulin sensitivity. Am J Physiol - Endocrinol Metab. 2010;299.E145-61.
   PubMed Web of Science ®Google Scholar
• Joseph AM, Hood DA. Relationships between exercise, mitochondrial biogenesis and type 2 diabetes. Diabetes Phys Act. 2014;60:48–61.
   Google Scholar
• Hou CY, Tain YL, Yu HR, et al. The effects of resveratrol in the treatment of metabolic syndrome. Int J Mol Sci. 2019;20:535. doi:10.3390/ijms20030535
   PubMed Web of Science ®Google Scholar
• Rodop BB, Erbaş O. Mitochondrial dysfunction in aging and disease: the role of nutrition. 2023. Available from: https://www.researchgate.net/publication/371071283.
   Google Scholar
• Das SK, Vasudevan DM. Alcohol-induced oxidative stress. Life Sci. 2007;81:177–187. doi:10.1016/j.lfs.2007.05.005
   PubMed Web of Science ®Google Scholar
• Horinouchi T, Higashi T, Mazaki Y, et al. Carbonyl compounds in the gas phase of cigarette mainstream smoke and their pharmacological properties. Biol Pharm Bull. 2016;39:909–914. doi:10.1248/bpb.b16-00025
   PubMed Web of Science ®Google Scholar
• Goel R, Bitzer Z, Reilly SM, et al. Variation in free radical yields from U.S. marketed cigarettes. Chem Res Toxicol. 2017;30:1038–1045. doi:10.1021/acs.chemrestox.6b00359
   PubMed Web of Science ®Google Scholar
• Sánchez-Rodríguez MA, Zacarías-Flores M, Correa-Muñoz E, et al. Oxidative stress risk is increased with a sedentary lifestyle during aging in Mexican women. Oxid Med Cell Longev. 2021;2021:9971765–9971765. doi:10.1155/2021/9971765
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Mancuso C, et al. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res. 2008;33:2444–2471. doi:10.1007/s11064-008-9775-9
   PubMed Web of Science ®Google Scholar
• Calabrese V, Cornelius C, Dinkova-Kostova AT, et al. Vitagenes,: cellular stress response, and acetylcarnitine: relevance to hormesis. BioFactors Oxf Engl. 2009;35:146–160. doi:10.1002/biof.22
   PubMed Web of Science ®Google Scholar
• Son TG, Camandola S, Mattson MP. Hormetic dietary phytochemicals. Neuromolecular Med. 2008;10:236–246. doi:10.1007/s12017-008-8037-y
   PubMed Web of Science ®Google Scholar
• Calabrese EJ. Another California milestone: the first application of Hormesis in litigation and regulation. Int J Toxicol. 2008;27:31–33. doi:10.1080/10915810701876554
   PubMed Web of Science ®Google Scholar
• Iqbal AM, Jamal SF. Essential Hypertension. Treasure Island (FL): StatPearls Publishing; 2023; [cited 2023 Jun 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK539859/.
   Google Scholar
• Muntner P, Carey RM, Gidding S, et al. Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation. 2018;137:109–118. doi:10.1161/CIRCULATIONAHA.117.032582
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–1324. doi:10.1161/HYP.0000000000000066
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hypertension [Internet]. 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension.
   Google Scholar
• Franco C, Sciatti E, Favero G, et al. Essential hypertension and oxidative stress: novel future perspectives. Int J Mol Sci. 2022;23(22):14489. Available from: /pmc/articles/PMC9692622/.
   Web of Science ®Google Scholar
• do Vale GT, Tirapelli CR. Are reactive oxygen species important mediators of vascular dysfunction? Curr Hypertens Rev. 2020;16:163–165. doi:10.2174/15734021OTgxdMTQaTcVY
   PubMed Web of Science ®Google Scholar
• Pan Y, Qiao QY, Pan LH, et al. Losartan reduces insulin resistance by inhibiting oxidative stress and enhancing insulin signaling transduction. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. 2015;123:170–177.
   PubMed Web of Science ®Google Scholar
• Rivasi G, Rafanelli M, Mossello E, et al. Drug-related orthostatic hypotension: beyond anti-hypertensive medications. Drugs Aging. 2020;37:725–738. doi:10.1007/s40266-020-00796-5
   PubMed Web of Science ®Google Scholar
• Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. Br Med J. 2013;346:e8525. doi:10.1136/bmj.e8525
   PubMed Web of Science ®Google Scholar
• Morris EJ, Brown JD, Manini TM, et al. Differences in health-related quality of life among adults with a potential dihydropyridine calcium channel blocker-loop diuretic prescribing cascade. Drugs Aging. 2021;38:625–632. doi:10.1007/s40266-021-00868-0
   PubMed Web of Science ®Google Scholar
• Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer’s disease. Lancet Lond Engl. 2021;397:1577–1577. doi:10.1016/S0140-6736(20)32205-4
   PubMed Web of Science ®Google Scholar
• Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement J Alzheimers Assoc. 2022;18:700–789. doi:10.1002/alz.12638
   PubMed Web of Science ®Google Scholar
• Andreone BJ, Lacoste B, Gu C. Neuronal and vascular interactions. Annu Rev Neurosci. 2015;38:25–46. doi:10.1146/annurev-neuro-071714-033835
   PubMed Web of Science ®Google Scholar
• Yoon JH, Seo Y, Jo YS, et al. Brain lipidomics: from functional landscape to clinical significance. Sci Adv. 2022;8:eadc9317. doi:10.1126/sciadv.adc9317
   PubMed Web of Science ®Google Scholar
• Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci U S A. 2004;101:2070–2070. doi:10.1073/pnas.0305799101
   PubMed Web of Science ®Google Scholar
• Shoeb M, Ansari NH, Srivastava SK, et al. 4-hydroxynonenal in the pathogenesis and progression of human diseases. Curr Med Chem. 2014;21:230–230. doi:10.2174/09298673113209990181
   PubMed Web of Science ®Google Scholar
• Singh M, Dang TN, Arseneault M, et al. Role of by-products of lipid oxidation in Alzheimer’s disease brain: a focus on acrolein. J Alzheimers Dis JAD. 2010;21:741–756. doi:10.3233/JAD-2010-100405
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev. 2013:316523. Available from: /pmc/articles/PMC3745981/
   Web of Science ®Google Scholar
• Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev. 2001;122:945–962. doi:10.1016/S0047-6374(01)00249-4
   PubMed Web of Science ®Google Scholar
• Ahmed N, Ahmed U, Thornalley PJ, et al. Protein glycation: oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer’s disease and link to cognitive impairment. J Neurochem. 2005;92:255–263. doi:10.1111/j.1471-4159.2004.02864.x
   PubMed Web of Science ®Google Scholar
• Al-Hilaly YK, Williams TL, Stewart-Parker M, et al. A central role for dityrosine crosslinking of amyloid-β in Alzheimer’s disease. Acta Neuropathol Commun. 2013;1:83. doi:10.1186/2051-5960-1-83
   PubMed Web of Science ®Google Scholar
• La Penna G, Hureau C, Andreussi O, et al. Identifying: by first-principles simulations, Cu[amyloid-β] species making Fenton-type reactions in Alzheimer’s disease. J Phys Chem B. 2013;117:16455–16467. doi:10.1021/jp410046w
   PubMed Web of Science ®Google Scholar
• Chen K, Jiang X, Wu M, et al. Ferroptosis, a potential therapeutic target in Alzheimer’s disease. Front Cell Dev Biol. 2021;9:704298. Available from: https://pubmed-ncbi-nlm-nih-gov.uchile.idm.oclc.org/34422824/.
   Web of Science ®Google Scholar
• Calabrese V, Mancuso C, Calvani M, et al. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci. 2007;8:766–775. doi:10.1038/nrn2214
   PubMed Web of Science ®Google Scholar
• Picón-Pagès P, Garcia-Buendia J, Muñoz FJ. Functions and dysfunctions of nitric oxide in brain. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1949–1967. doi:10.1016/j.bbadis.2018.11.007
   PubMed Web of Science ®Google Scholar
• Chachlaki K, Prevot V. Nitric oxide signalling in the brain and its control of bodily functions. Br J Pharmacol. 2020;177:5437–5458. doi:10.1111/bph.14800
   PubMed Web of Science ®Google Scholar
• Pomilio AB, Vitale AA, Lazarowski AJ. COVID-19 and Alzheimer’s disease: neuroinflammation: oxidative stress, ferroptosis, and mechanisms involved. Curr Med Chem. 2023;30(35):3993–4031.
   Web of Science ®Google Scholar
• Phillips MI, de Oliveira EM. Brain renin angiotensin in disease. J Mol Med Berl Ger. 2008;86:715–722. doi:10.1007/s00109-008-0331-5
   PubMed Web of Science ®Google Scholar
• Ababei D-C, Bild V, Macadan I, et al. Therapeutic implications of renin-angiotensin system modulators in Alzheimer’s dementia. Pharmaceutics. 2023;15:2290. doi:10.3390/pharmaceutics15092290
   PubMed Web of Science ®Google Scholar
• Hu W, Li Y, Zhao Y, et al. Telmisartan and Rosuvastatin synergistically ameliorate dementia and cognitive impairment in older hypertensive patients with apolipoprotein E genotype. Front Aging Neurosci. 2020;12:154. doi:10.3389/fnagi.2020.00154
   PubMed Web of Science ®Google Scholar
• Liu C-H, Sung P-S, Li Y-R, et al. Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: a population-based cohort study. PLoS Med. 2021;18:e1003707. doi:10.1371/journal.pmed.1003707
   PubMed Web of Science ®Google Scholar
• Sharma K. Cholinesterase inhibitors as Alzheimer’s therapeutics (Review). Mol Med Rep. 2019;20:1479–1487.
   PubMed Web of Science ®Google Scholar
• Sangaleti CT, Katayama KY, De Angelis K, et al. The cholinergic drug galantamine alleviates oxidative stress alongside anti-inflammatory and cardio-metabolic effects in subjects with the metabolic syndrome in a randomized trial. Front Immunol. 2021;12:613979. doi:10.3389/fimmu.2021.613979
   PubMed Web of Science ®Google Scholar
• Kundo NK, Manik MIN, Biswas K, et al. Identification of polyphenolics from Loranthus globosus as potential inhibitors of cholinesterase and oxidative stress for Alzheimer’s disease treatment. BioMed Res Int. 2021:9154406.
   PubMed Web of Science ®Google Scholar
• Althobaiti YS. Development of memantine as a drug for Alzheimer’s disease: a review of preclinical and clinical studies. Trop J Pharm Res. 2020;19:1535–1540. doi:10.4314/tjpr.v19i7.28
   Web of Science ®Google Scholar
• Matsunaga S, Kishi T, Nomura I, et al. The efficacy and safety of memantine for the treatment of Alzheimer’s disease. Expert Opin Drug Saf. 2018;17:1053–1061. doi:10.1080/14740338.2018.1524870
   PubMed Web of Science ®Google Scholar
• Guo J, Wang Z, Liu R, et al. Memantine, donepezil, or combination therapy-what is the best therapy for Alzheimer’s disease? A network meta-analysis. Brain Behav. 2020;10(11):e01831.
   Web of Science ®Google Scholar
• Press D, Buss S. Treatment of Alzheimer disease. Cholinesterase Inhib Treat Dement. 2021. Available from: https://www.uptodate.com/contents/treatment-of-alzheimer-disease
   Google Scholar
• Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet Lond Engl. 2020;396:413–446. doi:10.1016/S0140-6736(20)30367-6
   PubMed Web of Science ®Google Scholar
• Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage. 2022;30:184–195. doi:10.1016/j.joca.2021.04.020
   PubMed Web of Science ®Google Scholar
• Johnson VL, Hunter DJ. The epidemiology of osteoarthritis. Best Pract Res Clin Rheumatol. 2014;28:5–15. doi:10.1016/j.berh.2014.01.004
   PubMed Web of Science ®Google Scholar
• Hawker GA, King LK. The burden of osteoarthritis in older adults. Clin Geriatr Med. 2022;38:181–192. doi:10.1016/j.cger.2021.11.005
   PubMed Web of Science ®Google Scholar
• Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17:47–57. doi:10.1038/s41584-020-00533-7
   PubMed Web of Science ®Google Scholar
• Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–590. doi:10.1038/s41574-018-0059-4
   PubMed Web of Science ®Google Scholar
• Jeon OH, David N, Campisi J, et al. Senescent cells and osteoarthritis: a painful connection. J Clin Invest. 2018;128:1229–1237. doi:10.1172/JCI95147
   PubMed Web of Science ®Google Scholar
• Delmonico MJ, Harris TB, Visser M, et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr. 2009;90:1579–1579. doi:10.3945/ajcn.2009.28047
   PubMed Web of Science ®Google Scholar
• Sellam J, Berenbaum F. Is osteoarthritis a metabolic disease? Joint Bone Spine. 2013;80:568–573. doi:10.1016/j.jbspin.2013.09.007
   PubMed Web of Science ®Google Scholar
• Courties A, Gualillo O, Berenbaum F, et al. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 2015;23:1955–1965. doi:10.1016/j.joca.2015.05.016
   PubMed Web of Science ®Google Scholar
• Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12:412–412. doi:10.1038/nrrheum.2016.65
   PubMed Web of Science ®Google Scholar
• Gossan N, Zeef L, Hensman J, et al. The circadian clock in murine chondrocytes regulates genes controlling key aspects of cartilage homeostasis. Arthritis Rheum. 2013;65:2334–2345. doi:10.1002/art.38035
   PubMed Web of Science ®Google Scholar
• Jones DP. Redox theory of aging. Redox Biol. 2015;5:71–71. doi:10.1016/j.redox.2015.03.004
   PubMed Web of Science ®Google Scholar
• Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002;295:2450–2452. doi:10.1126/science.1069004
   PubMed Web of Science ®Google Scholar
• Mazumder S, De R, Debsharma S, et al. Indomethacin impairs mitochondrial dynamics by activating the PKCζ-p38-DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells. J Biol Chem. 2019;294:8238–8258. doi:10.1074/jbc.RA118.004415
   PubMed Web of Science ®Google Scholar
• Mazumder S, De R, Sarkar S, et al. Selective scavenging of intra-mitochondrial superoxide corrects diclofenac-induced mitochondrial dysfunction and gastric injury: a novel gastroprotective mechanism independent of gastric acid suppression. Biochem Pharmacol. 2016;121:33–51. doi:10.1016/j.bcp.2016.09.027
   PubMed Web of Science ®Google Scholar
• Koike M, Nojiri H, Ozawa Y, et al. Mechanical overloading causes mitochondrial superoxide and SOD2 imbalance in chondrocytes resulting in cartilage degeneration. Sci Rep. 2015;5:11722.
   PubMed Web of Science ®Google Scholar
• Hanachi N, Charef N, Baghiani A, et al. Comparison of xanthine oxidase levels in synovial fluid from patients with rheumatoid arthritis and other joint inflammations. Saudi Med J. 2009;30:1422–1425.
   PubMed Web of Science ®Google Scholar
• Yin W, Park JI, Loeser RF. Oxidative stress inhibits insulin-like growth factor-I induction of chondrocyte proteoglycan synthesis through differential regulation of phosphatidylinositol 3-Kinase-Akt and MEK-ERK MAPK signaling pathways. J Biol Chem. 2009;284:31972–31981. doi:10.1074/jbc.M109.056838
   PubMed Web of Science ®Google Scholar
• Wood ST, Long DL, Reisz JA, et al. Cysteine-mediated redox regulation of cell signaling in chondrocytes stimulated with fibronectin fragments. Arthritis Rheumatol Hoboken NJ. 2016;68:117–126. doi:10.1002/art.39326
   PubMed Web of Science ®Google Scholar
• Collins JA, Wood ST, Nelson KJ, et al. Oxidative stress promotes peroxiredoxin hyperoxidation and attenuates pro-survival signaling in aging chondrocytes. J Biol Chem. 2016;291:6641–6654. doi:10.1074/jbc.M115.693523
   PubMed Web of Science ®Google Scholar
• Miao Y, Chen Y, Xue F, et al. Contribution of ferroptosis and GPX4’s dual functions to osteoarthritis progression. EBioMedicine. 2022;76:103847 doi:10.1016/j.ebiom.2022.103847.
   PubMed Web of Science ®Google Scholar
• Bennell KL, Hunter DJ, Hinman RS. Management of osteoarthritis of the knee. Br Med J. 2012;345:e493410.1136/bmj.e4934.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22:363–388. doi:10.1016/j.joca.2014.01.003
   PubMed Web of Science ®Google Scholar
• Kompel AJ, Roemer FW, Murakami AM, et al. Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought? Radiology. 2019;293:656–663. doi:10.1148/radiol.2019190341
   PubMed Web of Science ®Google Scholar
• Sandoval-Acuña C, Lopez-Alarcón C, Aliaga ME, et al. Inhibition of mitochondrial complex I by various non-steroidal anti-inflammatory drugs and its protection by quercetin via a coenzyme Q-like action. Chem Biol Interact. 2012;199:18–28. doi:10.1016/j.cbi.2012.05.006
   PubMed Web of Science ®Google Scholar
• Shin SJ, Noh CK, Lim SG, et al. Non-steroidal anti-inflammatory drug-induced enteropathy. Intest Res. 2017;15:446–455. doi:10.5217/ir.2017.15.4.446
   PubMed Web of Science ®Google Scholar
• Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. J Gastroenterol. 2020;55:481–495. doi:10.1007/s00535-019-01657-8
   PubMed Web of Science ®Google Scholar
• Baigent C, Bhala N, Emberson J, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet Lond Engl. 2013;382:769–779. doi:10.1016/S0140-6736(13)60900-9
   PubMed Web of Science ®Google Scholar
• Huerta C, Castellsague J, Varas-Lorenzo C, et al. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45:531–539. doi:10.1053/j.ajkd.2004.12.005
   PubMed Web of Science ®Google Scholar
• Ory MG, Anderson LA, Friedman DB, et al. Cancer prevention among adults aged 45-64 years: setting the stage. Am J Prev Med. 2014;46:(3 Suppl 1):S1–6. doi:10.1016/j.amepre.2013.10.027.
   Web of Science ®Google Scholar
• Pilleron S, Sarfati D, Janssen-Heijnen M, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144:49–58. doi:10.1002/ijc.31664
   PubMed Web of Science ®Google Scholar
• Novak J, Goldberg A, Dharmarajan K, et al. Polypharmacy in older adults with cancer undergoing radiotherapy: a review. J Geriatr Oncol. 2022;13:778–778. doi:10.1016/j.jgo.2022.02.007
   PubMed Web of Science ®Google Scholar
• Zabłocka-Słowińska K, Płaczkowska S, Skórska K, et al. Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism. PLoS One. 2019;14:e0215246. doi:10.1371/journal.pone.0215246
   PubMed Web of Science ®Google Scholar
• Desouki MM, Kulawiec M, Bansal S, et al. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther. 2005;4:1367–1373. doi:10.4161/cbt.4.12.2233
   PubMed Web of Science ®Google Scholar
• Kawahara T, Kohjima M, Kuwano Y, et al. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am J Physiol - Cell Physiol. 2005;288(2):C450–7. doi:10.1152/ajpcell.00319.2004.
   PubMed Web of Science ®Google Scholar
• Fukuyama M, Rokutan K, Sano T, et al. Overexpression of a novel superoxide-producing enzyme, NADPH oxidase 1, in adenoma and well differentiated adenocarcinoma of the human colon. Cancer Lett. 2005;221:97–104. doi:10.1016/j.canlet.2004.08.031
   PubMed Web of Science ®Google Scholar
• Block K, Gorin Y, New DD, et al. The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. Am J Pathol. 2010;176:2447–2455. doi:10.2353/ajpath.2010.090606
   PubMed Web of Science ®Google Scholar
• Shimada K, Fujii T, Anai S, et al. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder. BMC Urol. 2011;11:1–12. doi:10.1186/1471-2490-11-1
   PubMed Web of Science ®Google Scholar
• Jitschin R, Hofmann AD, Bruns H, et al. Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia. Blood. 2014;123:2663–2672. doi:10.1182/blood-2013-10-532200
   PubMed Web of Science ®Google Scholar
• Hart PC, Mao M, De Abreu ALP, et al. MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat Commun. 2015;6:6053.
   PubMed Web of Science ®Google Scholar
• Foo BJ-A, Eu JQ, Hirpara JL, et al. Interplay between mitochondrial metabolism and cellular redox state dictates cancer cell survival. Oxid Med Cell Longev. 2021;2021:1341604.
   PubMed Web of Science ®Google Scholar
• Burdick AD, Davis JW, Liu KJ, et al. Benzo(a)pyrene quinones increase cell proliferation, generate reactive oxygen species, and transactivate the epidermal growth factor receptor in breast epithelial cells. Cancer Res. 2003;63:7825–7833.
   PubMed Web of Science ®Google Scholar
• Sarsour EH, Venkataraman S, Kalen AL, et al. Manganese superoxide dismutase activity regulates transitions between quiescent and proliferative growth. Aging Cell. 2008;7:405–417. doi:10.1111/j.1474-9726.2008.00384.x
   PubMed Web of Science ®Google Scholar
• Sieber OM, Heinimann K, Tomlinson IPM. Genomic instability - the engine of tumorigenesis? Nat Rev Cancer. 2003;3:701–708. doi:10.1038/nrc1170
   PubMed Web of Science ®Google Scholar
• Cooke MS, Evans MD, Dizdaroglu M, et al. Oxidative DNA damage: mechanisms: mutation, and disease. FASEB J. 2003;17:1195–1214. doi:10.1096/fj.02-0752rev
   PubMed Web of Science ®Google Scholar
• Moeller BJ, Cao Y, Li CY, et al. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation: free radicals, and stress granules. Cancer Cell. 2004;5:429–441. doi:10.1016/S1535-6108(04)00115-1
   PubMed Web of Science ®Google Scholar
• Xu RH, Pelicano H, Zhou Y, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613–621. doi:10.1158/0008-5472.613.65.2
   PubMed Web of Science ®Google Scholar
• Yoo NJ, Kim HR, Kim YR, et al. Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology. 2012;60:943–952. doi:10.1111/j.1365-2559.2012.04178.x
   PubMed Web of Science ®Google Scholar
• Sajadimajd S, Khazaei M. Oxidative stress and cancer: the role of Nrf2. Curr Cancer Drug Targets. 2018;18:538–557. doi:10.2174/1568009617666171002144228
   PubMed Web of Science ®Google Scholar
• Crociani O, Marzi I, Cipolleschi MG, et al. The unveiling of the Warburg effect and the inscribed innovative approach to a radical non toxic anticancer therapy. Cell Cycle Georget Tex. 2018;17:288–297. doi:10.1080/15384101.2017.1403679
   PubMed Web of Science ®Google Scholar
• Schiliro C, Firestein BL. Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells. 2021;10:1056. doi:10.3390/cells10051056
   PubMed Web of Science ®Google Scholar
• Chen H, Yan Z, Wu S, et al. A glutathione-responsive polyphenol - constructed nanodevice for double roles in apoptosis and ferroptosis. Colloids Surf B Biointerfaces. 2021;205:111902. doi:10.1016/j.colsurfb.2021.111902
   PubMed Web of Science ®Google Scholar
• Ghigo A, Li M, Hirsch E. New signal transduction paradigms in anthracycline-induced cardiotoxicity. Biochim Biophys Acta BBA - Mol Cell Res. 2016;1863:1916–1925. doi:10.1016/j.bbamcr.2016.01.021
   PubMed Web of Science ®Google Scholar
• Stephens C, Andrade RJ, Lucena MI. Mechanisms of drug-induced liver injury. Curr Opin Allergy Clin Immunol. 2014;14:286–292. doi:10.1097/ACI.0000000000000070
   PubMed Web of Science ®Google Scholar
• Baumgart SJ, Haendler B. Drug-induced liver injury: cascade of events leading to cell death, apoptosis or necrosis. Int J Mol Sci. 2017;18:E1018–E1018. doi:10.3390/ijms18051017
   PubMed Web of Science ®Google Scholar
• Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81:772–781. doi:10.1002/ana.24951
   PubMed Web of Science ®Google Scholar
• Ren X, Keeney JTR, Miriyala S, et al. The triangle of death of neurons: oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment (“chemobrain”) involving TNF-α. Free Radic Biol Med. 2018;134:1–8. doi:10.1016/j.freeradbiomed.2018.12.029
   PubMed Web of Science ®Google Scholar
• Herrmann J. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia. Nat Rev Cardiol. 2020;17:474–502. doi:10.1038/s41569-020-0348-1
   PubMed Web of Science ®Google Scholar
• McElroy T, Allen AR. A bibliometric review of publications on oxidative stress and chemobrain: 1990-2019. Antioxid Basel Switz. 2020;9:E439–E439. doi:10.3390/antiox9050439
   PubMed Web of Science ®Google Scholar
• Man Q, Deng Y, Li P, et al. Licorice ameliorates cisplatin-induced hepatotoxicity through antiapoptosis, antioxidative stress, anti-inflammation, and acceleration of metabolism. Front Pharmacol. 2020;11:563750–563750. doi:10.3389/fphar.2020.563750
   PubMed Web of Science ®Google Scholar
• Fabiani I, Aimo A, Grigoratos C, et al. Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets. Heart Fail Rev. 2020;26:881–890. doi:10.1007/s10741-020-10063-9
   PubMed Web of Science ®Google Scholar
• Pantazi D, Tselepis AD. Cardiovascular toxic effects of antitumor agents: pathogenetic mechanisms. Thromb Res. 2022;213:S95–102. doi:10.1016/j.thromres.2021.12.017
   PubMed Web of Science ®Google Scholar
• Li G, Ding K, Qiao Y, et al. Flavonoids regulate inflammation and oxidative stress in cancer. Molecules. 2020;25(23):5628. Available from: /pmc/articles/PMC7729519/.
   PubMed Web of Science ®Google Scholar
• Lee SG, Kim B, Yang Y, et al. Berry anthocyanins suppress the expression and secretion of proinflammatory mediators in macrophages by inhibiting nuclear translocation of NF-κB independent of NRF2-mediated mechanism. J Nutr Biochem. 2014;25:404–411. doi:10.1016/j.jnutbio.2013.12.001
   PubMed Web of Science ®Google Scholar
• Edirisinghe I, Banaszewski K, Cappozzo J, et al. Effect of black currant anthocyanins on the activation of endothelial nitric oxide synthase (eNOS) in vitro in human endothelial cells. J Agric Food Chem. 2011;59:8616–8624. doi:10.1021/jf201116y
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity [Internet]. Available from: https://www.who.int/health-topics/obesity#tab = tab_1.
   Google Scholar
• Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10. doi:10.1016/j.metabol.2018.09.005
   PubMed Web of Science ®Google Scholar
• Colleluori G, Villareal DT. Aging: obesity, sarcopenia and the effect of diet and exercise intervention. Exp Gerontol. 2021;155:111561. doi:10.1016/j.exger.2021.111561
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Le Lay S, Simard G, Martinez MC, et al. Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev. 2014;2014:908539. Available from: /pmc/articles/PMC4131099/.
   PubMed Web of Science ®Google Scholar
• Khalil A, Berrougui H. Mechanism of action of resveratrol in lipid metabolism and atherosclerosis. Clin. Lipidol. 2017;4:527–531. doi:10.2217/clp.09.53
   Google Scholar
• Meneses MJ, Silvestre R, Sousa-Lima I, et al. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders. Int J Mol Sci. 2019;20. doi:10.3390/ijms20164049
   PubMed Web of Science ®Google Scholar
• Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004;89:4963–4971. doi:10.1210/jc.2004-0305
   PubMed Web of Science ®Google Scholar
• Holvoet P. Relations between metabolic syndrome: oxidative stress and inflammation and cardiovascular disease. Verh K Acad Geneeskd Belg. 2008;70:193–219.
   PubMedGoogle Scholar
• Maingrette F, Renier G. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes. 2003;52:2121–2128. doi:10.2337/diabetes.52.8.2121
   PubMed Web of Science ®Google Scholar
• Chang C-C, Sia K-C, Chang J-F, et al. Participation of lipopolysaccharide in hyperplasic adipose expansion: involvement of NADPH oxidase/ROS/p42/p44 MAPK-dependent Cyclooxygenase-2. J Cell Mol Med. 2022;26:3850–3861. doi:10.1111/jcmm.17419
   PubMed Web of Science ®Google Scholar
• Silvester AJ, Aseer KR, Yun JW. Dietary polyphenols and their roles in fat browning. J Nutr Biochem. 2019;64:1–12. doi:10.1016/j.jnutbio.2018.09.028
   PubMed Web of Science ®Google Scholar
• Qiu H, Schlegel V. Impact of nutrient overload on metabolic homeostasis. Nutr Rev. 2018;76:693–707. doi:10.1093/nutrit/nuy023
   PubMed Web of Science ®Google Scholar
• Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis. 2017;1863:1066–1077. doi:10.1016/j.bbadis.2016.11.010
   PubMed Web of Science ®Google Scholar
• Bouchez C, Devin A. Mitochondrial biogenesis and mitochondrial reactive oxygen species (ROS): a complex relationship regulated by the cAMP/PKA signaling pathway. Cells. 2019;8:287. doi:10.3390/cells8040287
   PubMed Web of Science ®Google Scholar
• Mulero MC, Huxford T, Ghosh G. NF-κB, IκB, and IKK: integral components of immune system signaling. Adv Exp Med Biol. 2019;1172:207–226. doi:10.1007/978-981-13-9367-9_10
   PubMed Web of Science ®Google Scholar
• Oliveira-Marques V, Marinho HS, Cyrne L, et al. Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid Redox Signal. 2009;11:2223–2243. doi:10.1089/ars.2009.2601
   PubMed Web of Science ®Google Scholar
• Martínez-Martínez E, Jurado-López R, Valero-Muñoz M, et al. Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens. 2014;32:1104–1114. discussion 1114. doi:10.1097/HJH.0000000000000149
   PubMed Web of Science ®Google Scholar
• Xu X, Huang X, Zhang L, et al. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway. BMC Nephrol. 2021;22(1):218. doi:10.1186/s12882-021-02391-1.
   PubMed Web of Science ®Google Scholar
• Mitrou P, Boutati E, Lambadiari V, et al. Insulin resistance in hyperthyroidism: the role of IL6 and TNF alpha. Eur J Endocrinol. 2010;162:121–126. doi:10.1530/EJE-09-0622
   PubMed Web of Science ®Google Scholar
• Bjørklund G, Peana M, Pivina L, et al. Iron deficiency in obesity and after bariatric surgery. Biomolecules. 2021;11(5):613. doi:10.3390/biom11050613.
   PubMed Web of Science ®Google Scholar
• González-Domínguez Á, Visiedo-García FM, Domínguez-Riscart J, et al. Iron metabolism in obesity and metabolic syndrome. Int J Mol Sci. 2020;21:5529. doi:10.3390/ijms21155529
   PubMed Web of Science ®Google Scholar
• Sombra LRS, Anastasopoulou C Pharmacologic Therapy for Obesity. [Updated 2022 Aug 29] In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan. Available from: https://www-ncbi-nlm-nih-gov.uchile.idm.oclc.org/books/NBK562269/.
   Google Scholar
• Kawanami D, Takashi Y. GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms. Front Pharmacol. 2020;11:967. doi:10.3389/fphar.2020.00967
   PubMed Web of Science ®Google Scholar
• Mehdi SF, Pusapati S, Anwar MS, et al. Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent. Front Immunol. 2023;14:1148209. doi:10.3389/fimmu.2023.1148209
   PubMed Web of Science ®Google Scholar
• Hayes JD, Dinkova-Kostova AT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci. 2014;39:199–218. doi:10.1016/j.tibs.2014.02.002
   PubMed Web of Science ®Google Scholar
• Dinkova-Kostova AT, Abramov AY. The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med. 2015;88:179–188. doi:10.1016/j.freeradbiomed.2015.04.036
   PubMed Web of Science ®Google Scholar
• Mangmool S, Hemplueksa P, Parichatikanond W, et al. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes. Mol Endocrinol Baltim Md. 2015;29:583–596. doi:10.1210/me.2014-1346
   PubMedGoogle Scholar
• Fernández-Millán E, Martín MA, Goya L, et al. Glucagon-like peptide-1 improves beta-cell antioxidant capacity via extracellular regulated kinases pathway and Nrf2 translocation. Free Radic Biol Med. 2016;95:16–26. doi:10.1016/j.freeradbiomed.2016.03.002
   PubMed Web of Science ®Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:E153–E639.
   PubMed Web of Science ®Google Scholar
• Kattoor AJ, Pothineni NVK, Palagiri D, et al. Oxidative stress in atherosclerosis. Curr Atheroscler Rep. 2017;19:42. doi:10.1007/s11883-017-0678-6
   PubMed Web of Science ®Google Scholar
• Ford TJ, Corcoran D, Berry C. Stable coronary syndromes: pathophysiology: diagnostic advances and therapeutic need. Heart Br Card Soc. 2018;104:284–292.
   PubMed Web of Science ®Google Scholar
• King TC. Cell injury, cellular responses to injury, and cell death. Elseviers Integr Pathol. 2007: 1–20.
   Google Scholar
• Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning,: postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301. doi:10.1152/ajpheart.00553.2011
   PubMed Web of Science ®Google Scholar
• Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–229. doi:10.1016/B978-0-12-394309-5.00006-7
   PubMed Web of Science ®Google Scholar
• Yellon DM, Hausenloy DJ. Myocardial reperfusion injury [Internet]. Massachusetts Medical Society; 2007 [cited 2023 May 1]. Available from: https://www.nejm.org/doi/pdf/10.1056NEJMra071667.
   Google Scholar
• Algoet M, Janssens S, Himmelreich U, et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med. 2023;33:357–366. doi:10.1016/j.tcm.2022.02.005
   PubMed Web of Science ®Google Scholar
• Suski JM, Lebiedzinska M, Bonora M, et al. Relation between mitochondrial membrane potential and ROS formation. Methods Mol Biol Clifton NJ. 2012;810:183–205. doi:10.1007/978-1-61779-382-0_12
   PubMedGoogle Scholar
• Wu MY, Yiang GT, Liao WT, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46:1650–1667. doi:10.1159/000489241
   PubMed Web of Science ®Google Scholar
• Neri M, Fineschi V, Paolo M, et al. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 2015;13:26–36. doi:10.2174/15701611113119990003
   PubMed Web of Science ®Google Scholar
• Zhao ZQ, Nakamura M, Wang NP, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion. J Surg Res. 2000;94:133–144. doi:10.1006/jsre.2000.6029
   PubMed Web of Science ®Google Scholar
• Incalza MA, D’Oria R, Natalicchio A, et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19. doi:10.1016/j.vph.2017.05.005
   PubMed Web of Science ®Google Scholar
• Luo S, Lei H, Qin H, et al. Molecular mechanisms of endothelial NO synthase uncoupling. Curr Pharm Des. 2014;20:3548–3553. doi:10.2174/13816128113196660746
   PubMed Web of Science ®Google Scholar
• Garrido AM, Griendling KK. NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol. 2009;302:148–158. doi:10.1016/j.mce.2008.11.003
   PubMed Web of Science ®Google Scholar
• Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovasc Hematol Agents Med Chem. 2017;14:150–159. doi:10.2174/1871525714666161216100553
   PubMedGoogle Scholar
• Sima P, Vannucci L, Vetvicka V. Atherosclerosis as autoimmune disease. Ann Transl Med. 2018;6:116. doi:10.21037/atm.2018.02.02
   PubMed Web of Science ®Google Scholar
• Sato A, Ueda C, Kimura R, et al. Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein. Eur Biophys J EBJ. 2018;47:1–9. doi:10.1007/s00249-017-1208-8
   PubMed Web of Science ®Google Scholar
• Yeh HL, Kuo LT, Sung FC, et al. Association between polymorphisms of antioxidant gene (MnSOD, CAT, and GPx1) and risk of coronary artery disease. BioMed Res Int. 2018;2018:5086869. doi:10.1155/2018/5086869.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017;120:713–735. doi:10.1161/CIRCRESAHA.116.309326
   PubMed Web of Science ®Google Scholar
• Singh A, Museedi AS, Grossman SA. Acute coronary syndrome. StatPearls [Internet]. 2022; Available from: https://www-ncbi-nlm-nih-gov.uchile.idm.oclc.org/books/NBK459157/.
   Google Scholar
• Steinhubl SR. Why have antioxidants failed in clinical trials? Am J Cardiol. 2008;101(10A):14D–19D. doi:10.1016/j.amjcard.2008.02.003.
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Prieto JC, Aguayo R, et al. Joint cardioprotective effect of vitamin C and other antioxidants against reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Molecules. 2021;26:5702. doi:10.3390/molecules26185702
   PubMed Web of Science ®Google Scholar
• Ahmed S, Ahmed N, Rungatscher A, et al. Cocoa flavonoids reduce inflammation and oxidative stress in a myocardial ischemia-reperfusion experimental model. Antioxid Basel Switz. 2020;9:167. doi:10.3390/antiox9020167
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes Care. 2022;46:S19–S40. doi:10.2337/dc23-S002
   Web of Science ®Google Scholar
• International Diabetes Federation. IDF diabetes atlas 2021 | IDF Diabetes Atlas [Internet]. 2022. Available from: https://diabetesatlas.org/atlas/tenth-edition/.
   Google Scholar
• Papachristoforou E, Lambadiari V, Maratou E, et al. Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications. J Diabetes Res. 2020;2020:7489795. doi:10.1155/2020/7489795.
   PubMed Web of Science ®Google Scholar
• Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms: pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799. doi:10.1016/j.redox.2020.101799.
   PubMed Web of Science ®Google Scholar
• Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in diabetes mellitus and its complications and therapeutic approaches to correction. Bull Exp Biol Med. 2021;171:136–149. doi:10.47056/0365-9615-2021-171-2-136-149
   Web of Science ®Google Scholar
• Kiss L, Szabó C. The pathogenesis of diabetic complications: the role of DNA injury and poly(ADP-ribose) polymerase activation in peroxynitrite-mediated cytotoxicity. Mem Inst Oswaldo Cruz. 2005;100(Suppl 1):29–37. doi:10.1590/S0074-02762005000900007
   PubMedGoogle Scholar
• Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542. doi:10.3390/biom12040542.
   PubMed Web of Science ®Google Scholar
• Baghaie L, Bunsick DA, Szewczuk MR. Insulin receptor signaling in health and disease. Biomolecules. 2023;13:807–807. doi:10.3390/biom13050807
   PubMed Web of Science ®Google Scholar
• Howes KA, Liu Y, Dunaief JL, et al. Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:3713–3720. doi:10.1167/iovs.04-0404
   PubMed Web of Science ®Google Scholar
• Moldogazieva NT, Mokhosoev IM, Mel’Nikova TI, et al. Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases. Oxid Med Cell Longev. 2019;2019:3085756. doi:10.1155/2019/3085756.
   PubMed Web of Science ®Google Scholar
• Lorenzi M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res. 2007;2007:61038. doi:10.1155/2007/61038.
   PubMedGoogle Scholar
• Cho S-J, Roman G, Yeboah F, et al. The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem. 2007;14:1653–1671. doi:10.2174/092986707780830989
   PubMed Web of Science ®Google Scholar
• Inoguchi T, Li P, Umeda F, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C–dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939–1945. doi:10.2337/diabetes.49.11.1939
   PubMed Web of Science ®Google Scholar
• Faramoushi M, Amir Sasan R, Sari Sarraf V, et al. Cardiac fibrosis and down regulation of GLUT4 in experimental diabetic cardiomyopathy are ameliorated by chronic exposures to intermittent altitude. J Cardiovasc Thorac Res. 2016;8:26–33. doi:10.15171/jcvtr.2016.05
   PubMed Web of Science ®Google Scholar
• Pacher P, Szabó C. Role of poly(ADP-ribose) polymerase-1 activation in the pathogenesis of diabetic complications: endothelial dysfunction, as a common underlying theme. Antioxid Redox Signal. 2005;7:1568–1580. doi:10.1089/ars.2005.7.1568
   PubMed Web of Science ®Google Scholar
• Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr Clin Res Rev. 2019;13:1165–1172. doi:10.1016/j.dsx.2019.01.040
   PubMed Web of Science ®Google Scholar
• Luc K, Schramm-Luc A, Guzik TJ, et al. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol Off J Pol Physiol Soc. 2019;70(6):809–824. doi:10.26402/jpp.2019.6.01.
   Web of Science ®Google Scholar
• Krogh-Madsen R, Møller K, Dela F, et al. Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-alpha, and FFAs to low-dose endotoxemia in humans. Am J Physiol Endocrinol Metab. 2004;286(5):E766–72. doi:10.1152/ajpendo.00468.2003.
   PubMed Web of Science ®Google Scholar
• Akbari M, Hassan-Zadeh V. IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology. 2018;26:685–698. doi:10.1007/s10787-018-0458-0
   PubMed Web of Science ®Google Scholar
• Yaribeygi H, Sathyapalan T, Atkin SL, et al. Molecular mechanisms linking oxidative stress and diabetes mellitus. Oxid Med Cell Longev. 2020;2020:8609213. doi:10.1155/2020/8609213
   PubMed Web of Science ®Google Scholar
• Zhang P, Li T, Wu X, et al. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14:583–600. doi:10.1007/s11684-019-0729-1
   PubMed Web of Science ®Google Scholar
• Fonseca SG, Gromada J, Urano F. Endoplasmic reticulum stress and pancreatic β-cell death. Trends Endocrinol Metab TEM. 2011;22:266–274.
   PubMed Web of Science ®Google Scholar
• Torres-Castro I, Arroyo-Camarena ÚD, Martínez-Reyes CP, et al. Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose. Immunol Lett. 2016;176:81–89. doi:10.1016/j.imlet.2016.06.001
   PubMed Web of Science ®Google Scholar
• Alexopoulos AS, Kahkoska AR, Pate V, et al. Deintensification of treatment with sulfonylurea and insulin after severe hypoglycemia among older adults with diabetes. JAMA Netw Open. 2021;4(11):e2132215. doi:10.1001/jamanetworkopen.2021.32215.
   PubMed Web of Science ®Google Scholar
• Nam YH, Brensinger CM, Bilker WB, et al. Serious hypoglycemia and use of warfarin in combination with sulfonylureas or metformin. Clin Pharmacol Ther. 2019;105:210–218. doi:10.1002/cpt.1146
   PubMed Web of Science ®Google Scholar
• Wang G, Wang Y, Yang Q, et al. Metformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo. Cell Death Dis. 2022;13(1):29. doi:10.1038/s41419-021-04478-x.
   PubMed Web of Science ®Google Scholar
• Katila N, Bhurtel S, Park PH, et al. Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT/Nrf2 pathway. Neurochem Int. 2021;148:105120. doi:10.1016/j.neuint.2021.105120.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu L, Jiang Y, et al. Protective effect of metformin against hydrogen peroxide-induced oxidative damage in human retinal pigment epithelial (RPE) cells by enhancing autophagy through activation of AMPK pathway. Oxid Med Cell Longev. 2020;2020:2524174. doi:10.1155/2020/2524174.
   PubMed Web of Science ®Google Scholar
• Padki MM, Stambler I. Encycl Gerontol Popul Aging. Targeting Aging with Metformin (TAME). Springer, Cham; 2021. p. 4098–4910. doi:10.1007/978-3-030-22009-9_400.
   Google Scholar
• Mohammed I, Hollenberg MD, Ding H, et al. A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Front Endocrinol. 2021;12:718942.
   PubMed Web of Science ®Google Scholar
• Apostolova N, Iannantuoni F, Gruevska A, et al. Mechanisms of action of metformin in type 2 diabetes: effects on mitochondria and leukocyte-endothelium interactions. Redox Biol. 2020;34:101517. 10.1016/j.redox.2020.101517.
   PubMed Web of Science ®Google Scholar
• Zenebe Y, Akele B, W/Selassie M, et al. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20:55. doi:10.1186/s12991-021-00375-x
   PubMed Web of Science ®Google Scholar
• Inoue K, Beekley J, Goto A, et al. Depression and cardiovascular disease events among patients with type 2 diabetes: A systematic review and meta-analysis with bias analysis. J Diabetes Complications. 2020;34:107710. doi:10.1016/j.jdiacomp.2020.107710
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. Arlington (VA): American Psychiatric Association; 2010.
   Google Scholar
• Tedeschini E, Levkovitz Y, Iovieno N, et al. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. J Clin Psychiatry. 2011;72:1660–1668. doi:10.4088/JCP.10r06531
   PubMed Web of Science ®Google Scholar
• Calvi A, Fischetti I, Verzicco I, et al. Antidepressant drugs effects on blood pressure. Front Cardiovasc Med. 2021;8:704281. doi:10.3389/fcvm.2021.704281
   PubMed Web of Science ®Google Scholar
• Mercurio M, de Filippis R, Spina G, et al. The use of antidepressants is linked to bone loss: a systematic review and metanalysis. Orthop Rev. 2022;14:38564.
   Web of Science ®Google Scholar
• Miguel C, Albuquerque E. Drug interaction in psycho-oncology: antidepressants and antineoplastics. Pharmacology. 2011;88:333–339. doi:10.1159/000334738
   PubMed Web of Science ®Google Scholar
• Byeon E, Park JC, Hagiwara A, et al. Two antidepressants fluoxetine and sertraline cause growth retardation and oxidative stress in the marine rotifer Brachionus koreanus. Aquat Toxicol Amst Neth. 2020;218:105337. doi:10.1016/j.aquatox.2019.105337
   PubMed Web of Science ®Google Scholar
• Khanzode SD, Dakhale GN, Khanzode SS, et al. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep Commun Free Radic Res. 2003;8:365–370.
   PubMed Web of Science ®Google Scholar
• Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12:7–11. doi:10.1016/j.kisu.2021.11.003
   PubMed Web of Science ®Google Scholar
• Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of haemodialysis outcomes. Nat Rev Nephrol. 2022;18:378–395. doi:10.1038/s41581-022-00542-7
   PubMed Web of Science ®Google Scholar
• Canaud B, Tong L, Tentori F, et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol CJASN. 2011;6:1651–1662. doi:10.2215/CJN.03530410
   PubMed Web of Science ®Google Scholar
• Vodošek Hojs N, Bevc S, Ekart R, et al. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants. 2020;9:925. doi:10.3390/antiox9100925
   Web of Science ®Google Scholar
• Irazabal MV, Torres VE. Reactive oxygen species and redox signaling in chronic kidney disease. Cells. 2020;9:1342. doi:10.3390/cells9061342
   PubMed Web of Science ®Google Scholar
• Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59:1960–1966. doi:10.1046/j.1523-1755.2001.0590051960.x
   PubMed Web of Science ®Google Scholar
• Tarng DC, Huang TP, Wei YH, et al. 8-hydroxy-2’-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis Off J Natl Kidney Found. 2000;36:934–944. doi:10.1053/ajkd.2000.19086
   PubMed Web of Science ®Google Scholar
• Shimoike T, Inoguchi T, Umeda F, et al. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy. Metabolism. 2000;49:1030–1035. doi:10.1053/meta.2000.7738
   PubMed Web of Science ®Google Scholar
• Dozio E, Caldiroli L, Molinari P, et al. Accelerated AGEing: the impact of advanced glycation end products on the prognosis of chronic kidney disease. Antioxidants. 2023;12:584. doi:10.3390/antiox12030584
   Web of Science ®Google Scholar
• Kato H, Watanabe H, Imafuku T, et al. Advanced oxidation protein products contribute to chronic kidney disease-induced muscle atrophy by inducing oxidative stress via CD36/NADPH oxidase pathway. J Cachexia Sarcopenia Muscle. 2021;12:1832–1847. doi:10.1002/jcsm.12786
   PubMed Web of Science ®Google Scholar
• Ravarotto V, Bertoldi G, Innico G, et al. The pivotal role of oxidative stress in the pathophysiology of cardiovascular-renal remodeling in kidney disease. Antioxidants. 2021;10:1041. doi:10.3390/antiox10071041
   Web of Science ®Google Scholar
• Satou R, Cypress MW, Woods TC, et al. Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells. Am J Physiol - Ren Physiol. 2020;318:F67–F75. doi:10.1152/ajprenal.00402.2019
   PubMed Web of Science ®Google Scholar
• Zaibi N, Li P, Xu S-Z. Protective effects of dapagliflozin against oxidative stress-induced cell injury in human proximal tubular cells. PLoS One. 2021;16:e0247234. doi:10.1371/journal.pone.0247234
   PubMed Web of Science ®Google Scholar
• Hasan R, Lasker S, Hasan A, et al. Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK–Akt–eNOS pathway in the isoprenaline-induced oxidative stress model. Sci Rep. 2020;10:14659. doi:10.1038/s41598-020-71599-2
   PubMed Web of Science ®Google Scholar
• Das NA, Carpenter AJ, Belenchia A, et al. Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition. Cell Signal. 2020;68:109506. doi:10.1016/j.cellsig.2019.109506
   PubMed Web of Science ®Google Scholar
• Fang R, Chen J, Long J, et al. Empagliflozin improves kidney senescence induced by d-galactose by reducing sirt1-mediated oxidative stress. Biogerontology. 2023;24:771–782. doi:10.1007/s10522-023-10038-x
   PubMed Web of Science ®Google Scholar
• Semo D, Obergassel J, Dorenkamp M, et al. The sodium-glucose co-transporter 2 (SGLT2) inhibitor empagliflozin reverses hyperglycemia-induced monocyte and endothelial dysfunction primarily through glucose transport-independent but redox-dependent mechanisms. J Clin Med. 2023;12:1356. doi:10.3390/jcm12041356
   PubMed Web of Science ®Google Scholar
• Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20:392–397. doi:10.1016/j.amjhyper.2006.09.021
   PubMed Web of Science ®Google Scholar
• Tessier DM, Khalil A, Trottier L, et al. Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes. Arch Gerontol Geriatr. 2009;48:67–72. doi:10.1016/j.archger.2007.10.005
   PubMed Web of Science ®Google Scholar
• Mazloom Z, Hejazi N, Dabbaghmanesh M-H, et al. Effect of vitamin C supplementation on postprandial oxidative stress and lipid profile in type 2 diabetic patients. Pak J Biol Sci PJBS. 2011;14:900–904. doi:10.3923/pjbs.2011.900.904
   PubMedGoogle Scholar
• Ulker S, McKeown PP, Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertens Dallas Tex 1979. 2003;41:534–539.
   Google Scholar
• Boonthongkaew C, Tong-Un T, Kanpetta Y, et al. Vitamin C supplementation improves blood pressure and oxidative stress after acute exercise in patients with poorly controlled type 2 diabetes mellitus: a randomized,: placebo-controlled, cross-over study. Chin J Physiol. 2021;64:16–23. doi:10.4103/cjp.cjp_95_20
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Prat H, Passalacqua W, et al. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Clin Sci Lond Engl 1979. 2008;114:625–634.
   Google Scholar
• Hajjar IM, George V, Sasse EA, et al. A randomized: double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther. 2002;9:289–293. doi:10.1097/00045391-200207000-00005
   PubMedGoogle Scholar
• Guan Y, Dai P, Wang H. Effects of vitamin C supplementation on essential hypertension: a systematic review and meta-analysis. Medicine (Baltimore. 2020;99:e19274. doi:10.1097/MD.0000000000019274
   PubMed Web of Science ®Google Scholar
• Sato K, Dohi Y, Kojima M, et al. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung. 2006;56:535–540.
   PubMed Web of Science ®Google Scholar
• Mason SA, Della Gatta PA, Snow RJ, et al. Ascorbic acid supplementation improves skeletal muscle oxidative stress and insulin sensitivity in people with type 2 diabetes: findings of a randomized controlled study. Free Radic Biol Med. 2016;93:227–238. doi:10.1016/j.freeradbiomed.2016.01.006
   PubMed Web of Science ®Google Scholar
• El-Aal AA, El-Ghffar EAA, Ghali AA, et al. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: a single-blinded randomized controlled clinical trial. Diabetes Metab Syndr. 2018;12:483–489. doi:10.1016/j.dsx.2018.03.013
   PubMed Web of Science ®Google Scholar
• Mason SA, Rasmussen B, van Loon LJC, et al. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: findings of a randomized cross-over trial. Diabetes Obes Metab. 2019;21:674–682. doi:10.1111/dom.13571
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Rahmat A, Patimah I, et al. Effect of vitamin C on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Drug Des Devel Ther. 2015;9:3405–3412. doi:10.2147/DDDT.S83144
   PubMed Web of Science ®Google Scholar
• Fraga CG, Croft KD, Kennedy DO, et al. The effects of polyphenols and other bioactives on human health. Food Funct. 2019;10:514–528. doi:10.1039/C8FO01997E
   PubMed Web of Science ®Google Scholar
• Serban M-C, Sahebkar A, Zanchetti A, et al. Effects of quercetin on blood pressure: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2016;5:e002713.
   PubMed Web of Science ®Google Scholar
• Brüll V, Burak C, Stoffel-Wagner B, et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr. 2015;114:1263–1277. doi:10.1017/S0007114515002950
   PubMed Web of Science ®Google Scholar
• Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 2009;102:1065–1074. doi:10.1017/S0007114509359127
   PubMed Web of Science ®Google Scholar
• Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int J Mol Sci. 2019;20:1523. doi:10.3390/ijms20071523
   PubMed Web of Science ®Google Scholar
• Sweeney M, Burns G, Sturgeon N, et al. The effects of berry polyphenols on the gut microbiota and blood pressure: a systematic review of randomized clinical trials in humans. Nutrients. 2022;14:2263. doi:10.3390/nu14112263
   PubMedGoogle Scholar
• Vetrani C, Vitale M, Bozzetto L, et al. Association between different dietary polyphenol subclasses and the improvement in cardiometabolic risk factors: evidence from a randomized controlled clinical trial. Acta Diabetol. 2018;55:149–153. doi:10.1007/s00592-017-1075-x
   PubMed Web of Science ®Google Scholar
• Mokgalaboni K, Ntamo Y, Ziqubu K, et al. Curcumin supplementation improves biomarkers of oxidative stress and inflammation in conditions of obesity, type 2 diabetes and NAFLD: updating the status of clinical evidence. Food Funct. 2021;12:12235–12249. doi:10.1039/D1FO02696H
   PubMed Web of Science ®Google Scholar
• Witte AV, Kerti L, Margulies DS, et al. Effects of resveratrol on memory performance: hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014;34:7862–7870. doi:10.1523/JNEUROSCI.0385-14.2014
   PubMed Web of Science ®Google Scholar
• Mahjabeen W, Khan DA, Mirza SA. Role of resveratrol supplementation in regulation of glucose hemostasis: inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial. Complement Ther Med. 2022;66:102819. doi:10.1016/j.ctim.2022.102819
   PubMed Web of Science ®Google Scholar
• Du C, Smith A, Avalos M, et al. Blueberries improve pain, gait performance, and inflammation in individuals with symptomatic knee osteoarthritis. Nutrients. 2019;11:290. doi:10.3390/nu11020290
   PubMed Web of Science ®Google Scholar
• Hussain SA, Marouf BH, Ali ZS, et al. Efficacy and safety of co-administration of resveratrol with meloxicam in patients with knee osteoarthritis: a pilot interventional study. Clin Interv Aging. 2018;13:1621–1630. doi:10.2147/CIA.S172758
   PubMed Web of Science ®Google Scholar
• Ávila-Gálvez MÁ, González-Sarrías A, Martínez-Díaz F, et al. Disposition of dietary polyphenols in breast cancer patients’ tumors, and their associated anticancer activity: the particular case of curcumin. Mol Nutr Food Res. 2021;65:2100163. doi:10.1002/mnfr.202100163
   Web of Science ®Google Scholar
• Huhn S, Beyer F, Zhang R, et al. Effects of resveratrol on memory performance, hippocampus connectivity and microstructure in older adults - a randomized controlled trial. NeuroImage. 2018;174:177–190. doi:10.1016/j.neuroimage.2018.03.023
   PubMed Web of Science ®Google Scholar
• Moussa C, Hebron M, Huang X, et al. Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease. J Neuroinflammation. 2017;14:1. doi:10.1186/s12974-016-0779-0
   PubMed Web of Science ®Google Scholar
• Baum L, Lam CWK, Cheung SK-K, et al. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol. 2008;28:110–113. doi:10.1097/jcp.0b013e318160862c
   PubMed Web of Science ®Google Scholar
• Kumar P, Liu C, Suliburk J, et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. J Gerontol A Biol Sci Med Sci. 2023;78:75–89. doi:10.1093/gerona/glac135
   PubMed Web of Science ®Google Scholar
• Hashemi G, Mirjalili M, Basiri Z, et al. A pilot study to evaluate the effects of oral N-acetyl cysteine on inflammatory and oxidative stress biomarkers in rheumatoid arthritis. Curr Rheumatol Rev. 2019;15:246–253. doi:10.2174/1573403X14666180926100811
   PubMed Web of Science ®Google Scholar
• Esalatmanesh K, Jamali A, Esalatmanesh R, et al. Effects of N-acetylcysteine supplementation on disease activity: oxidative stress, and inflammatory and metabolic parameters in rheumatoid arthritis patients: a randomized double-blind placebo-controlled trial. Amino Acids. 2022;54:433–440. doi:10.1007/s00726-022-03134-8
   PubMed Web of Science ®Google Scholar
• Batooei M, Tahamoli-Roudsari A, Basiri Z, et al. Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Rev Recent Clin Trials. 2018;13:132–138. doi:10.2174/1574887113666180307151937
   PubMed Web of Science ®Google Scholar
• Adair JC, Knoefel JE, Morgan N. Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease. Neurology. 2001;57:1515–1517. doi:10.1212/WNL.57.8.1515
   PubMed Web of Science ®Google Scholar
• Remington R, Chan A, Paskavitz J, et al. Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer’s disease: a placebo-controlled pilot study. Am J Alzheimers Dis Dementias. 2009;24:27–33. doi:10.1177/1533317508325094
   PubMed Web of Science ®Google Scholar
• Chan A, Paskavitz J, Remington R, et al. Efficacy of a vitamin/nutriceutical formulation for early-stage Alzheimer’s disease: a 1-year, open-label pilot study with an 16-month caregiver extension. Am J Alzheimers Dis Dementias. 2009;23:571–585. doi:10.1177/1533317508325093
   Web of Science ®Google Scholar
• Remington R, Bechtel C, Larsen D, et al. A phase II randomized clinical trial of a nutritional formulation for cognition and mood in Alzheimer’s disease. J Alzheimers Dis JAD. 2015;45:395–405. doi:10.3233/JAD-142499
   PubMed Web of Science ®Google Scholar
• Skvarc DR, Dean OM, Byrne LK, et al. The effect of N-acetylcysteine (NAC) on human cognition – a systematic review. Neurosci Biobehav Rev. 2017;78:44–56. doi:10.1016/j.neubiorev.2017.04.013
   PubMed Web of Science ®Google Scholar
• Fasipe B, Faria A, Laher I. Potential for novel therapeutic uses of alpha lipoic acid. Curr Med Chem. 2023;30:3942–3954. doi:10.2174/0929867329666221006115329
   PubMed Web of Science ®Google Scholar
• Rezaei Zonooz S, Hasani M, Morvaridzadeh M, et al. Effect of alpha-lipoic acid on oxidative stress parameters: a systematic review and meta-analysis. J Funct Foods. 2021;87:104774. doi:10.1016/j.jff.2021.104774
   Web of Science ®Google Scholar
• Jeffrey S, Isaac Samraj P, Sundara Raj B. Therapeutic benefits of alpha-lipoic acid supplementation in diabetes mellitus: a narrative review. J Diet Suppl. 2022;19:566–586. doi:10.1080/19390211.2021.2020387
   PubMed Web of Science ®Google Scholar
• Derosa G, D’Angelo A, Romano D, et al. A clinical trial about a food supplement containing α-lipoic acid on oxidative stress markers in type 2 diabetic patients. Int J Mol Sci. 2016;17:1802. doi:10.3390/ijms17111802
   PubMed Web of Science ®Google Scholar
• Mendoza-Núñez VM, García-Martínez BI, Rosado-Pérez J, et al. The effect of 600 mg alpha-lipoic acid supplementation on oxidative stress, inflammation, and RAGE in older adults with type 2 diabetes mellitus. Oxid Med Cell Longev. 2019;2019:3276958.
   PubMed Web of Science ®Google Scholar
• Gianturco V, Bellomo A, D’ottavio E, et al. Impact of therapy with α-lipoic acid (ALA) on the oxidative stress in the controlled niddm: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr. 2009;49:129–133. doi:10.1016/j.archger.2009.09.022
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu F-X. α-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur Rev Med Pharmacol Sci. 2014;18:3715–3719.
   PubMed Web of Science ®Google Scholar
• Porasuphatana S, Suddee S, Nartnampong A, et al. Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study. Asia Pac J Clin Nutr. 2012;21:12–21.
   PubMed Web of Science ®Google Scholar
• Khabbazi T, Mahdavi R, Safa J, et al. Effects of alpha-lipoic acid supplementation on inflammation: oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis. J Ren Nutr. 2012;22:244–250. doi:10.1053/j.jrn.2011.06.005
   PubMed Web of Science ®Google Scholar
• Ramos LF, Kane J, McMonagle E, et al. Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2011;21:211–218.
   Google Scholar
• Himmelfarb J, Ikizler TA, Ellis C, et al. Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial. J Am Soc Nephrol JASN. 2014;25:623–633. doi:10.1681/ASN.2013050545
   PubMed Web of Science ®Google Scholar
• Mahdavi R, Khabbazi T, Safa J. Alpha lipoic acid supplementation improved antioxidant enzyme activities in hemodialysis patients. Int J Vitam Nutr Res Int Z Vitam- Ernahrungsforschung J Int Vitaminol Nutr. 2019;89:161–167. doi:10.1024/0300-9831/a000552
   PubMed Web of Science ®Google Scholar
• Abdel Hamid DZ, Nienaa YA, Mostafa TM. Alpha-lipoic acid improved anemia: erythropoietin resistance, maintained glycemic control, and reduced cardiovascular risk in diabetic patients on hemodialysis: a multi-center prospective randomized controlled study. Eur Rev Med Pharmacol Sci. 2022;26:2313–2329.
   PubMed Web of Science ®Google Scholar
• Díaz-Casado ME, Quiles JL, Barriocanal-Casado E, et al. The paradox of coenzyme Q10 in aging. Nutrients. 2019;11:2221. doi:10.3390/nu11092221
   PubMedGoogle Scholar
• Hargreaves I, Heaton RA, Mantle D. Disorders of human coenzyme Q10 metabolism: an overview. Int J Mol Sci. 2020;21:6695. doi:10.3390/ijms21186695
   PubMed Web of Science ®Google Scholar
• Hargreaves IP, Mantle D. Coenzyme Q10 supplementation in fibrosis and aging. Adv Exp Med Biol. 2019;1178:103–112. doi:10.1007/978-3-030-25650-0_6
   PubMed Web of Science ®Google Scholar
• Lee B-J, Huang Y-C, Chen S-J, et al. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition. 2012;28:250–255. doi:10.1016/j.nut.2011.06.004
   PubMed Web of Science ®Google Scholar
• Yeung CK, Billings FT, Claessens AJ, et al. Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress. BMC Nephrol. 2015;16:183. doi:10.1186/s12882-015-0178-2
   PubMed Web of Science ®Google Scholar
• Rivara MB, Yeung CK, Robinson-Cohen C, et al. Effect of coenzyme Q10 on biomarkers of oxidative stress and cardiac function in hemodialysis patients: the CoQ10 biomarker trial. Am J Kidney Dis Off J Natl Kidney Found. 2017;69:389–399. doi:10.1053/j.ajkd.2016.08.041
   PubMed Web of Science ®Google Scholar
• The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342:154–160. doi:10.1056/NEJM200001203420302
   PubMed Web of Science ®Google Scholar
• Lee I-M, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294:56–65. doi:10.1001/jama.294.1.56
   PubMed Web of Science ®Google Scholar
• Nascimento MM, Suliman ME, Silva M, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Perit Dial Int J Int Soc Perit Dial. 2010;30:336–342. doi:10.3747/pdi.2009.00073
   PubMed Web of Science ®Google Scholar
• Renke M, Tylicki L, Rutkowski P, et al. The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over study. Med Sci Monit Int Med J Exp Clin Res. 2010;16:PI13–PI18.
   Google Scholar
• Zhang Y, Han P, Wu N, et al. Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects. Obesity. 2011;19:1647–1653. doi:10.1038/oby.2011.121
   PubMed Web of Science ®Google Scholar
• Bobe G, Michels AJ, Zhang W-J, et al. A randomized controlled trial of long-term (R)-α-lipoic acid supplementation promotes weight loss in overweight or obese adults without altering baseline elevated plasma triglyceride concentrations. J Nutr. 2020;150:2336–2345. doi:10.1093/jn/nxaa203
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Mazooji N, Roozbeh J, et al. Effect of alpha-lipoic acid and vitamin E supplementation on oxidative stress,: inflammation, and malnutrition in hemodialysis patients. Iran J Kidney Dis. 2013;7:461–467.
   PubMed Web of Science ®Google Scholar
• Pérez-Torres I, Guarner-Lans V, Rubio-Ruiz ME. Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents. Int J Mol Sci. 2017;18:2098. doi:10.3390/ijms18102098
   PubMed Web of Science ®Google Scholar